Ernexa Therapeutics Inc.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Brooklyn ImmunoTherapeutics
  • Eterna Therapeutics
  • Novellus Therapeutics
See more in Biomedtracker

Latest on Ernexa Therapeutics Inc.

Scrip

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St

Scrip

Deal Watch: Dianthus Will Reach Public Markets Via Reverse Merger With Stalled-Out Magenta

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Newly Public Dianthus Projects Financia

Scrip

Deal Watch: Moderna, ElevateBio Subsidiary To Combine mRNA With Gene Editing

 
• By Joseph Haas, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Busy Moderna Inks Gene-Editing Pact Wit

Scrip

Tech Transfer Roundup: MD Anderson, NCI Lead Cancer Alliances

 
• By Joseph Haas

The pace of cancer partnering between the biopharma industry and academic and institutional research entities during the final months of 2022 remained typically brisk, and two US institutions – The U